These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39390760)

  • 1. Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.
    Wang X; Ma S; Twardowski P; Lau C; Chan YS; Wong K; Xiao S; Wang J; Wu X; Frankel P; Wilson TG; Synold TW; Presant C; Dorff T; Yu J; Sadava D; Chen S
    Clin Transl Med; 2024 Oct; 14(10):e70048. PubMed ID: 39390760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft.
    Wang X; Ha D; Mori H; Chen S
    J Nutr Biochem; 2021 Mar; 89():108580. PubMed ID: 33388344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses.
    Twardowski P; Kanaya N; Frankel P; Synold T; Ruel C; Pal SK; Junqueira M; Prajapati M; Moore T; Tryon P; Chen S
    Cancer; 2015 Sep; 121(17):2942-50. PubMed ID: 25989179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White button mushroom interrupts tissue AR-mediated TMPRSS2 expression and attenuates pro-inflammatory cytokines in C57BL/6 mice.
    Wang X; Ha D; Yoshitake R; Chen S
    NPJ Sci Food; 2021 Aug; 5(1):20. PubMed ID: 34341347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
    Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
    Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
    J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma.
    Li X; Liu J; Xing Z; Tang J; Sun H; Zhang X; Lv S; Chen Z; Shi M; Chen M; Zuo S; Lyu X; He Y
    J Leukoc Biol; 2021 Dec; 110(6):1143-1161. PubMed ID: 34636072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer.
    Youn JI; Park SM; Park S; Kim G; Lee HJ; Son J; Hong MH; Ghaderpour A; Baik B; Islam J; Choi JW; Lee EY; Kim HR; Seo SU; Paik S; Yoon HI; Jung I; Xin CF; Jin HT; Cho BC; Seong SY; Ha SJ; Kim HR
    Sci Rep; 2020 Jun; 10(1):9050. PubMed ID: 32493990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
    Chen Z; Yang X; Chen Z; Li M; Wang W; Yang R; Wang Z; Ma Y; Xu Y; Ao S; Liang L; Cai C; Wang C; Deng T; Gu D; Zhou H; Zeng G
    BMC Med; 2023 Oct; 21(1):402. PubMed ID: 37880708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
    Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart.
    Pelosi A; Besi F; Tumino N; Merli P; Quatrini L; Li Pira G; Algeri M; Moretta L; Vacca P
    Front Immunol; 2021; 12():657329. PubMed ID: 33986748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
    Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
    J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
    Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.